Measured Mobility
The Quality of a Stretch
Two people can perform the same stretch at the same angle for the same duration and achieve very different outcomes. Until now, stretch quality has never truly been measured. Traditional slant boards can confirm that a stretch occurred, but they cannot evaluate how well it was performed. Angle alone is not enough. Time alone is not enough. Quality is what ultimately determines results.
AcuFlex™ is Powered By
Measuring what was previously invisible.
AcuFlex is a precision, sensor-enabled slant board paired with secure software.
It captures high-frequency, real-time data across multiple sensors, evaluating how a stretch is performed, not just whether it occurred.
For the first time, stretch quality becomes:
- Objective
- Individualized
- Trackable over time
Better Data Changes Everything
AcuFlex evaluates:
Consistency
Symmetry
Load behavior
Execution quality
With session history and trend visualization, clinicians can:
- Compare left and right performance
- Identify asymmetries
- Monitor progress across sessions
- Detect early regression
Data transforms stretching from subjective prescription into measurable intervention.
From Rehab to Prehab
Most injuries develop gradually, long before symptoms.
Subtle mobility deficits. Load imbalances. Execution breakdown.
AcuFlex digital slant board helps identify those changes early.
For athletics and military populations, this means:
- Proactive mobility monitoring
- Reduced injury risk
- Improved readiness
- Data-informed progression decisions
Prehab is no longer theoretical. It’s quantified.
Seamless Integration. Meaningful Insight.
Precision Without Complexity
AcuFlex supports identifying risk and smarter recovery, without changing workflows or adding unnecessary complexity.
Built for real-world environments.
Engineered for secure, HIPAA-compliant data protection.
Designed for scalable adoption.
"It’s not just about stretching anymore — it’s about stretching right, tracking progress, and preventing injuries before they start."
Dr. J. Michael Davis, MD
CEO & Clinical Visionary
